CRNX CIK: 1658247

Crinetics Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.34
FY22:
0.35
FY23:
0.57
FY24:
1.38
FY25:
1.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.06
FY24:
0.06
FY25:
0.08
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.35
FY23:
0.64
FY24:
1.43
FY25:
1.13

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.03
FY23:
0.04
FY24:
0.06
FY25:
0.09
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.01
FY23:
0.05
FY24:
0.05
FY25:
0.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.32
FY23:
0.54
FY24:
1.32
FY25:
0.99
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.35
FY22:
0.35
FY23:
0.64
FY24:
1.43
FY25:
1.13

All amounts in billions USD Data source:SEC EDGAR